inQB8 Medical Technologies

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, inQB8 Medical Technologies sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

inQB8 Medical Technologies: 1 sponsored US clinical trial, 1 recruiting.

inQB8 Medical Technologies sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Tricuspid Valve Regurgitation, with 1 trials.

Mid-pack sponsor footprint

inQB8 Medical Technologies is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Clinical Study of the inQB8 TTVR System

NCT06611579

Therapeutic Areas

Tricuspid Valve Regurgitation 1

What is open in the inQB8 Medical Technologies pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Tricuspid Valve Regurgitation (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

inQB8 Medical Technologies: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

inQB8 Medical Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share inQB8 Medical Technologies1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
inQB8 Medical Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

inQB8 Medical Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this inQB8 Medical Technologies page

1 registered trials is a research-attention snapshot, not an endorsement of inQB8 Medical Technologies or any single study.

  • 1 of inQB8 Medical Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Tricuspid Valve Regurgitation is the condition inQB8 Medical Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Tricuspid Valve Regurgitation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

inQB8 Medical Technologies pipeline card: 1 registered trials from official public datasets.Report a data error.